Global Multicancer Detection Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Multicancer Detection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Multicancer Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Multicancer Detection market size and forecasts, in consumption value ($ Million), 2018-2029
Global Multicancer Detection market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Multicancer Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Multicancer Detection market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Multicancer Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Multicancer Detection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Inc., Atara Biotherapeutics, Inc., Burning Rock DX, Danaher Corporation and Exact Sciences Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Multicancer Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Multicancer Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Multicancer Detection, with revenue, gross margin and global market share of Multicancer Detection from 2018 to 2023.
Chapter 3, the Multicancer Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Multicancer Detection market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Multicancer Detection.
Chapter 13, to describe Multicancer Detection research findings and conclusion.
This report is a detailed and comprehensive analysis for global Multicancer Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Multicancer Detection market size and forecasts, in consumption value ($ Million), 2018-2029
Global Multicancer Detection market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Multicancer Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Multicancer Detection market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Multicancer Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Multicancer Detection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Inc., Atara Biotherapeutics, Inc., Burning Rock DX, Danaher Corporation and Exact Sciences Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Multicancer Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Laboratory Developed Tests (LDTs)
- In-Vitro Diagnostics (IVDs)
- Hospital
- Clinic
- Agilent Technologies, Inc.
- Atara Biotherapeutics, Inc.
- Burning Rock DX
- Danaher Corporation
- Exact Sciences Corporation
- Hoffmann-La Roche Ltd
- Fulgent Genetics.
- Genecast Biotechnology Co., Ltd
- Guardant Health, Inc.
- Illumina, Inc.
- Konica Minolta, Inc.
- Laboratory Corporation of America Holdings.
- Myriad Genetics, Inc.
- Tempus
- Thermo Fisher Scientific Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Multicancer Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Multicancer Detection, with revenue, gross margin and global market share of Multicancer Detection from 2018 to 2023.
Chapter 3, the Multicancer Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Multicancer Detection market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Multicancer Detection.
Chapter 13, to describe Multicancer Detection research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Multicancer Detection
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Multicancer Detection by Type
1.3.1 Overview: Global Multicancer Detection Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Multicancer Detection Consumption Value Market Share by Type in 2022
1.3.3 Laboratory Developed Tests (LDTs)
1.3.4 In-Vitro Diagnostics (IVDs)
1.4 Global Multicancer Detection Market by Application
1.4.1 Overview: Global Multicancer Detection Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Multicancer Detection Market Size & Forecast
1.6 Global Multicancer Detection Market Size and Forecast by Region
1.6.1 Global Multicancer Detection Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Multicancer Detection Market Size by Region, (2018-2029)
1.6.3 North America Multicancer Detection Market Size and Prospect (2018-2029)
1.6.4 Europe Multicancer Detection Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Multicancer Detection Market Size and Prospect (2018-2029)
1.6.6 South America Multicancer Detection Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Multicancer Detection Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. Multicancer Detection Product and Solutions
2.1.4 Agilent Technologies, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.2 Atara Biotherapeutics, Inc.
2.2.1 Atara Biotherapeutics, Inc. Details
2.2.2 Atara Biotherapeutics, Inc. Major Business
2.2.3 Atara Biotherapeutics, Inc. Multicancer Detection Product and Solutions
2.2.4 Atara Biotherapeutics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Atara Biotherapeutics, Inc. Recent Developments and Future Plans
2.3 Burning Rock DX
2.3.1 Burning Rock DX Details
2.3.2 Burning Rock DX Major Business
2.3.3 Burning Rock DX Multicancer Detection Product and Solutions
2.3.4 Burning Rock DX Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Burning Rock DX Recent Developments and Future Plans
2.4 Danaher Corporation
2.4.1 Danaher Corporation Details
2.4.2 Danaher Corporation Major Business
2.4.3 Danaher Corporation Multicancer Detection Product and Solutions
2.4.4 Danaher Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Danaher Corporation Recent Developments and Future Plans
2.5 Exact Sciences Corporation
2.5.1 Exact Sciences Corporation Details
2.5.2 Exact Sciences Corporation Major Business
2.5.3 Exact Sciences Corporation Multicancer Detection Product and Solutions
2.5.4 Exact Sciences Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Exact Sciences Corporation Recent Developments and Future Plans
2.6 Hoffmann-La Roche Ltd
2.6.1 Hoffmann-La Roche Ltd Details
2.6.2 Hoffmann-La Roche Ltd Major Business
2.6.3 Hoffmann-La Roche Ltd Multicancer Detection Product and Solutions
2.6.4 Hoffmann-La Roche Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.7 Fulgent Genetics.
2.7.1 Fulgent Genetics. Details
2.7.2 Fulgent Genetics. Major Business
2.7.3 Fulgent Genetics. Multicancer Detection Product and Solutions
2.7.4 Fulgent Genetics. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fulgent Genetics. Recent Developments and Future Plans
2.8 Genecast Biotechnology Co., Ltd
2.8.1 Genecast Biotechnology Co., Ltd Details
2.8.2 Genecast Biotechnology Co., Ltd Major Business
2.8.3 Genecast Biotechnology Co., Ltd Multicancer Detection Product and Solutions
2.8.4 Genecast Biotechnology Co., Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Genecast Biotechnology Co., Ltd Recent Developments and Future Plans
2.9 Guardant Health, Inc.
2.9.1 Guardant Health, Inc. Details
2.9.2 Guardant Health, Inc. Major Business
2.9.3 Guardant Health, Inc. Multicancer Detection Product and Solutions
2.9.4 Guardant Health, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guardant Health, Inc. Recent Developments and Future Plans
2.10 Illumina, Inc.
2.10.1 Illumina, Inc. Details
2.10.2 Illumina, Inc. Major Business
2.10.3 Illumina, Inc. Multicancer Detection Product and Solutions
2.10.4 Illumina, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Illumina, Inc. Recent Developments and Future Plans
2.11 Konica Minolta, Inc.
2.11.1 Konica Minolta, Inc. Details
2.11.2 Konica Minolta, Inc. Major Business
2.11.3 Konica Minolta, Inc. Multicancer Detection Product and Solutions
2.11.4 Konica Minolta, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Konica Minolta, Inc. Recent Developments and Future Plans
2.12 Laboratory Corporation of America Holdings.
2.12.1 Laboratory Corporation of America Holdings. Details
2.12.2 Laboratory Corporation of America Holdings. Major Business
2.12.3 Laboratory Corporation of America Holdings. Multicancer Detection Product and Solutions
2.12.4 Laboratory Corporation of America Holdings. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Laboratory Corporation of America Holdings. Recent Developments and Future Plans
2.13 Myriad Genetics, Inc.
2.13.1 Myriad Genetics, Inc. Details
2.13.2 Myriad Genetics, Inc. Major Business
2.13.3 Myriad Genetics, Inc. Multicancer Detection Product and Solutions
2.13.4 Myriad Genetics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.14 Tempus
2.14.1 Tempus Details
2.14.2 Tempus Major Business
2.14.3 Tempus Multicancer Detection Product and Solutions
2.14.4 Tempus Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Tempus Recent Developments and Future Plans
2.15 Thermo Fisher Scientific Inc.
2.15.1 Thermo Fisher Scientific Inc. Details
2.15.2 Thermo Fisher Scientific Inc. Major Business
2.15.3 Thermo Fisher Scientific Inc. Multicancer Detection Product and Solutions
2.15.4 Thermo Fisher Scientific Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Multicancer Detection Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Multicancer Detection by Company Revenue
3.2.2 Top 3 Multicancer Detection Players Market Share in 2022
3.2.3 Top 6 Multicancer Detection Players Market Share in 2022
3.3 Multicancer Detection Market: Overall Company Footprint Analysis
3.3.1 Multicancer Detection Market: Region Footprint
3.3.2 Multicancer Detection Market: Company Product Type Footprint
3.3.3 Multicancer Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Multicancer Detection Consumption Value and Market Share by Type (2018-2023)
4.2 Global Multicancer Detection Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Multicancer Detection Consumption Value Market Share by Application (2018-2023)
5.2 Global Multicancer Detection Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Multicancer Detection Consumption Value by Type (2018-2029)
6.2 North America Multicancer Detection Consumption Value by Application (2018-2029)
6.3 North America Multicancer Detection Market Size by Country
6.3.1 North America Multicancer Detection Consumption Value by Country (2018-2029)
6.3.2 United States Multicancer Detection Market Size and Forecast (2018-2029)
6.3.3 Canada Multicancer Detection Market Size and Forecast (2018-2029)
6.3.4 Mexico Multicancer Detection Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Multicancer Detection Consumption Value by Type (2018-2029)
7.2 Europe Multicancer Detection Consumption Value by Application (2018-2029)
7.3 Europe Multicancer Detection Market Size by Country
7.3.1 Europe Multicancer Detection Consumption Value by Country (2018-2029)
7.3.2 Germany Multicancer Detection Market Size and Forecast (2018-2029)
7.3.3 France Multicancer Detection Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Multicancer Detection Market Size and Forecast (2018-2029)
7.3.5 Russia Multicancer Detection Market Size and Forecast (2018-2029)
7.3.6 Italy Multicancer Detection Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Multicancer Detection Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Multicancer Detection Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Multicancer Detection Market Size by Region
8.3.1 Asia-Pacific Multicancer Detection Consumption Value by Region (2018-2029)
8.3.2 China Multicancer Detection Market Size and Forecast (2018-2029)
8.3.3 Japan Multicancer Detection Market Size and Forecast (2018-2029)
8.3.4 South Korea Multicancer Detection Market Size and Forecast (2018-2029)
8.3.5 India Multicancer Detection Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Multicancer Detection Market Size and Forecast (2018-2029)
8.3.7 Australia Multicancer Detection Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Multicancer Detection Consumption Value by Type (2018-2029)
9.2 South America Multicancer Detection Consumption Value by Application (2018-2029)
9.3 South America Multicancer Detection Market Size by Country
9.3.1 South America Multicancer Detection Consumption Value by Country (2018-2029)
9.3.2 Brazil Multicancer Detection Market Size and Forecast (2018-2029)
9.3.3 Argentina Multicancer Detection Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Multicancer Detection Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Multicancer Detection Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Multicancer Detection Market Size by Country
10.3.1 Middle East & Africa Multicancer Detection Consumption Value by Country (2018-2029)
10.3.2 Turkey Multicancer Detection Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Multicancer Detection Market Size and Forecast (2018-2029)
10.3.4 UAE Multicancer Detection Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Multicancer Detection Market Drivers
11.2 Multicancer Detection Market Restraints
11.3 Multicancer Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Multicancer Detection Industry Chain
12.2 Multicancer Detection Upstream Analysis
12.3 Multicancer Detection Midstream Analysis
12.4 Multicancer Detection Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Multicancer Detection
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Multicancer Detection by Type
1.3.1 Overview: Global Multicancer Detection Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Multicancer Detection Consumption Value Market Share by Type in 2022
1.3.3 Laboratory Developed Tests (LDTs)
1.3.4 In-Vitro Diagnostics (IVDs)
1.4 Global Multicancer Detection Market by Application
1.4.1 Overview: Global Multicancer Detection Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Multicancer Detection Market Size & Forecast
1.6 Global Multicancer Detection Market Size and Forecast by Region
1.6.1 Global Multicancer Detection Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Multicancer Detection Market Size by Region, (2018-2029)
1.6.3 North America Multicancer Detection Market Size and Prospect (2018-2029)
1.6.4 Europe Multicancer Detection Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Multicancer Detection Market Size and Prospect (2018-2029)
1.6.6 South America Multicancer Detection Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Multicancer Detection Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. Multicancer Detection Product and Solutions
2.1.4 Agilent Technologies, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.2 Atara Biotherapeutics, Inc.
2.2.1 Atara Biotherapeutics, Inc. Details
2.2.2 Atara Biotherapeutics, Inc. Major Business
2.2.3 Atara Biotherapeutics, Inc. Multicancer Detection Product and Solutions
2.2.4 Atara Biotherapeutics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Atara Biotherapeutics, Inc. Recent Developments and Future Plans
2.3 Burning Rock DX
2.3.1 Burning Rock DX Details
2.3.2 Burning Rock DX Major Business
2.3.3 Burning Rock DX Multicancer Detection Product and Solutions
2.3.4 Burning Rock DX Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Burning Rock DX Recent Developments and Future Plans
2.4 Danaher Corporation
2.4.1 Danaher Corporation Details
2.4.2 Danaher Corporation Major Business
2.4.3 Danaher Corporation Multicancer Detection Product and Solutions
2.4.4 Danaher Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Danaher Corporation Recent Developments and Future Plans
2.5 Exact Sciences Corporation
2.5.1 Exact Sciences Corporation Details
2.5.2 Exact Sciences Corporation Major Business
2.5.3 Exact Sciences Corporation Multicancer Detection Product and Solutions
2.5.4 Exact Sciences Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Exact Sciences Corporation Recent Developments and Future Plans
2.6 Hoffmann-La Roche Ltd
2.6.1 Hoffmann-La Roche Ltd Details
2.6.2 Hoffmann-La Roche Ltd Major Business
2.6.3 Hoffmann-La Roche Ltd Multicancer Detection Product and Solutions
2.6.4 Hoffmann-La Roche Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.7 Fulgent Genetics.
2.7.1 Fulgent Genetics. Details
2.7.2 Fulgent Genetics. Major Business
2.7.3 Fulgent Genetics. Multicancer Detection Product and Solutions
2.7.4 Fulgent Genetics. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fulgent Genetics. Recent Developments and Future Plans
2.8 Genecast Biotechnology Co., Ltd
2.8.1 Genecast Biotechnology Co., Ltd Details
2.8.2 Genecast Biotechnology Co., Ltd Major Business
2.8.3 Genecast Biotechnology Co., Ltd Multicancer Detection Product and Solutions
2.8.4 Genecast Biotechnology Co., Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Genecast Biotechnology Co., Ltd Recent Developments and Future Plans
2.9 Guardant Health, Inc.
2.9.1 Guardant Health, Inc. Details
2.9.2 Guardant Health, Inc. Major Business
2.9.3 Guardant Health, Inc. Multicancer Detection Product and Solutions
2.9.4 Guardant Health, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guardant Health, Inc. Recent Developments and Future Plans
2.10 Illumina, Inc.
2.10.1 Illumina, Inc. Details
2.10.2 Illumina, Inc. Major Business
2.10.3 Illumina, Inc. Multicancer Detection Product and Solutions
2.10.4 Illumina, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Illumina, Inc. Recent Developments and Future Plans
2.11 Konica Minolta, Inc.
2.11.1 Konica Minolta, Inc. Details
2.11.2 Konica Minolta, Inc. Major Business
2.11.3 Konica Minolta, Inc. Multicancer Detection Product and Solutions
2.11.4 Konica Minolta, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Konica Minolta, Inc. Recent Developments and Future Plans
2.12 Laboratory Corporation of America Holdings.
2.12.1 Laboratory Corporation of America Holdings. Details
2.12.2 Laboratory Corporation of America Holdings. Major Business
2.12.3 Laboratory Corporation of America Holdings. Multicancer Detection Product and Solutions
2.12.4 Laboratory Corporation of America Holdings. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Laboratory Corporation of America Holdings. Recent Developments and Future Plans
2.13 Myriad Genetics, Inc.
2.13.1 Myriad Genetics, Inc. Details
2.13.2 Myriad Genetics, Inc. Major Business
2.13.3 Myriad Genetics, Inc. Multicancer Detection Product and Solutions
2.13.4 Myriad Genetics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.14 Tempus
2.14.1 Tempus Details
2.14.2 Tempus Major Business
2.14.3 Tempus Multicancer Detection Product and Solutions
2.14.4 Tempus Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Tempus Recent Developments and Future Plans
2.15 Thermo Fisher Scientific Inc.
2.15.1 Thermo Fisher Scientific Inc. Details
2.15.2 Thermo Fisher Scientific Inc. Major Business
2.15.3 Thermo Fisher Scientific Inc. Multicancer Detection Product and Solutions
2.15.4 Thermo Fisher Scientific Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Multicancer Detection Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Multicancer Detection by Company Revenue
3.2.2 Top 3 Multicancer Detection Players Market Share in 2022
3.2.3 Top 6 Multicancer Detection Players Market Share in 2022
3.3 Multicancer Detection Market: Overall Company Footprint Analysis
3.3.1 Multicancer Detection Market: Region Footprint
3.3.2 Multicancer Detection Market: Company Product Type Footprint
3.3.3 Multicancer Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Multicancer Detection Consumption Value and Market Share by Type (2018-2023)
4.2 Global Multicancer Detection Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Multicancer Detection Consumption Value Market Share by Application (2018-2023)
5.2 Global Multicancer Detection Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Multicancer Detection Consumption Value by Type (2018-2029)
6.2 North America Multicancer Detection Consumption Value by Application (2018-2029)
6.3 North America Multicancer Detection Market Size by Country
6.3.1 North America Multicancer Detection Consumption Value by Country (2018-2029)
6.3.2 United States Multicancer Detection Market Size and Forecast (2018-2029)
6.3.3 Canada Multicancer Detection Market Size and Forecast (2018-2029)
6.3.4 Mexico Multicancer Detection Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Multicancer Detection Consumption Value by Type (2018-2029)
7.2 Europe Multicancer Detection Consumption Value by Application (2018-2029)
7.3 Europe Multicancer Detection Market Size by Country
7.3.1 Europe Multicancer Detection Consumption Value by Country (2018-2029)
7.3.2 Germany Multicancer Detection Market Size and Forecast (2018-2029)
7.3.3 France Multicancer Detection Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Multicancer Detection Market Size and Forecast (2018-2029)
7.3.5 Russia Multicancer Detection Market Size and Forecast (2018-2029)
7.3.6 Italy Multicancer Detection Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Multicancer Detection Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Multicancer Detection Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Multicancer Detection Market Size by Region
8.3.1 Asia-Pacific Multicancer Detection Consumption Value by Region (2018-2029)
8.3.2 China Multicancer Detection Market Size and Forecast (2018-2029)
8.3.3 Japan Multicancer Detection Market Size and Forecast (2018-2029)
8.3.4 South Korea Multicancer Detection Market Size and Forecast (2018-2029)
8.3.5 India Multicancer Detection Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Multicancer Detection Market Size and Forecast (2018-2029)
8.3.7 Australia Multicancer Detection Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Multicancer Detection Consumption Value by Type (2018-2029)
9.2 South America Multicancer Detection Consumption Value by Application (2018-2029)
9.3 South America Multicancer Detection Market Size by Country
9.3.1 South America Multicancer Detection Consumption Value by Country (2018-2029)
9.3.2 Brazil Multicancer Detection Market Size and Forecast (2018-2029)
9.3.3 Argentina Multicancer Detection Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Multicancer Detection Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Multicancer Detection Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Multicancer Detection Market Size by Country
10.3.1 Middle East & Africa Multicancer Detection Consumption Value by Country (2018-2029)
10.3.2 Turkey Multicancer Detection Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Multicancer Detection Market Size and Forecast (2018-2029)
10.3.4 UAE Multicancer Detection Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Multicancer Detection Market Drivers
11.2 Multicancer Detection Market Restraints
11.3 Multicancer Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Multicancer Detection Industry Chain
12.2 Multicancer Detection Upstream Analysis
12.3 Multicancer Detection Midstream Analysis
12.4 Multicancer Detection Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Multicancer Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Multicancer Detection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Multicancer Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Multicancer Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Agilent Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies, Inc. Major Business
Table 7. Agilent Technologies, Inc. Multicancer Detection Product and Solutions
Table 8. Agilent Technologies, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Agilent Technologies, Inc. Recent Developments and Future Plans
Table 10. Atara Biotherapeutics, Inc. Company Information, Head Office, and Major Competitors
Table 11. Atara Biotherapeutics, Inc. Major Business
Table 12. Atara Biotherapeutics, Inc. Multicancer Detection Product and Solutions
Table 13. Atara Biotherapeutics, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Atara Biotherapeutics, Inc. Recent Developments and Future Plans
Table 15. Burning Rock DX Company Information, Head Office, and Major Competitors
Table 16. Burning Rock DX Major Business
Table 17. Burning Rock DX Multicancer Detection Product and Solutions
Table 18. Burning Rock DX Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Burning Rock DX Recent Developments and Future Plans
Table 20. Danaher Corporation Company Information, Head Office, and Major Competitors
Table 21. Danaher Corporation Major Business
Table 22. Danaher Corporation Multicancer Detection Product and Solutions
Table 23. Danaher Corporation Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Danaher Corporation Recent Developments and Future Plans
Table 25. Exact Sciences Corporation Company Information, Head Office, and Major Competitors
Table 26. Exact Sciences Corporation Major Business
Table 27. Exact Sciences Corporation Multicancer Detection Product and Solutions
Table 28. Exact Sciences Corporation Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Exact Sciences Corporation Recent Developments and Future Plans
Table 30. Hoffmann-La Roche Ltd Company Information, Head Office, and Major Competitors
Table 31. Hoffmann-La Roche Ltd Major Business
Table 32. Hoffmann-La Roche Ltd Multicancer Detection Product and Solutions
Table 33. Hoffmann-La Roche Ltd Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Table 35. Fulgent Genetics. Company Information, Head Office, and Major Competitors
Table 36. Fulgent Genetics. Major Business
Table 37. Fulgent Genetics. Multicancer Detection Product and Solutions
Table 38. Fulgent Genetics. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Fulgent Genetics. Recent Developments and Future Plans
Table 40. Genecast Biotechnology Co., Ltd Company Information, Head Office, and Major Competitors
Table 41. Genecast Biotechnology Co., Ltd Major Business
Table 42. Genecast Biotechnology Co., Ltd Multicancer Detection Product and Solutions
Table 43. Genecast Biotechnology Co., Ltd Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Genecast Biotechnology Co., Ltd Recent Developments and Future Plans
Table 45. Guardant Health, Inc. Company Information, Head Office, and Major Competitors
Table 46. Guardant Health, Inc. Major Business
Table 47. Guardant Health, Inc. Multicancer Detection Product and Solutions
Table 48. Guardant Health, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Guardant Health, Inc. Recent Developments and Future Plans
Table 50. Illumina, Inc. Company Information, Head Office, and Major Competitors
Table 51. Illumina, Inc. Major Business
Table 52. Illumina, Inc. Multicancer Detection Product and Solutions
Table 53. Illumina, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Illumina, Inc. Recent Developments and Future Plans
Table 55. Konica Minolta, Inc. Company Information, Head Office, and Major Competitors
Table 56. Konica Minolta, Inc. Major Business
Table 57. Konica Minolta, Inc. Multicancer Detection Product and Solutions
Table 58. Konica Minolta, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Konica Minolta, Inc. Recent Developments and Future Plans
Table 60. Laboratory Corporation of America Holdings. Company Information, Head Office, and Major Competitors
Table 61. Laboratory Corporation of America Holdings. Major Business
Table 62. Laboratory Corporation of America Holdings. Multicancer Detection Product and Solutions
Table 63. Laboratory Corporation of America Holdings. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Laboratory Corporation of America Holdings. Recent Developments and Future Plans
Table 65. Myriad Genetics, Inc. Company Information, Head Office, and Major Competitors
Table 66. Myriad Genetics, Inc. Major Business
Table 67. Myriad Genetics, Inc. Multicancer Detection Product and Solutions
Table 68. Myriad Genetics, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Myriad Genetics, Inc. Recent Developments and Future Plans
Table 70. Tempus Company Information, Head Office, and Major Competitors
Table 71. Tempus Major Business
Table 72. Tempus Multicancer Detection Product and Solutions
Table 73. Tempus Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Tempus Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Inc. Major Business
Table 77. Thermo Fisher Scientific Inc. Multicancer Detection Product and Solutions
Table 78. Thermo Fisher Scientific Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 80. Global Multicancer Detection Revenue (USD Million) by Players (2018-2023)
Table 81. Global Multicancer Detection Revenue Share by Players (2018-2023)
Table 82. Breakdown of Multicancer Detection by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Multicancer Detection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Multicancer Detection Players
Table 85. Multicancer Detection Market: Company Product Type Footprint
Table 86. Multicancer Detection Market: Company Product Application Footprint
Table 87. Multicancer Detection New Market Entrants and Barriers to Market Entry
Table 88. Multicancer Detection Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Multicancer Detection Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Multicancer Detection Consumption Value Share by Type (2018-2023)
Table 91. Global Multicancer Detection Consumption Value Forecast by Type (2024-2029)
Table 92. Global Multicancer Detection Consumption Value by Application (2018-2023)
Table 93. Global Multicancer Detection Consumption Value Forecast by Application (2024-2029)
Table 94. North America Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Multicancer Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Multicancer Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Multicancer Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Multicancer Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Multicancer Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Multicancer Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Multicancer Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Multicancer Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Multicancer Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Multicancer Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Multicancer Detection Raw Material
Table 125. Key Suppliers of Multicancer Detection Raw Materials
Table 1. Global Multicancer Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Multicancer Detection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Multicancer Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Multicancer Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Agilent Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies, Inc. Major Business
Table 7. Agilent Technologies, Inc. Multicancer Detection Product and Solutions
Table 8. Agilent Technologies, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Agilent Technologies, Inc. Recent Developments and Future Plans
Table 10. Atara Biotherapeutics, Inc. Company Information, Head Office, and Major Competitors
Table 11. Atara Biotherapeutics, Inc. Major Business
Table 12. Atara Biotherapeutics, Inc. Multicancer Detection Product and Solutions
Table 13. Atara Biotherapeutics, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Atara Biotherapeutics, Inc. Recent Developments and Future Plans
Table 15. Burning Rock DX Company Information, Head Office, and Major Competitors
Table 16. Burning Rock DX Major Business
Table 17. Burning Rock DX Multicancer Detection Product and Solutions
Table 18. Burning Rock DX Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Burning Rock DX Recent Developments and Future Plans
Table 20. Danaher Corporation Company Information, Head Office, and Major Competitors
Table 21. Danaher Corporation Major Business
Table 22. Danaher Corporation Multicancer Detection Product and Solutions
Table 23. Danaher Corporation Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Danaher Corporation Recent Developments and Future Plans
Table 25. Exact Sciences Corporation Company Information, Head Office, and Major Competitors
Table 26. Exact Sciences Corporation Major Business
Table 27. Exact Sciences Corporation Multicancer Detection Product and Solutions
Table 28. Exact Sciences Corporation Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Exact Sciences Corporation Recent Developments and Future Plans
Table 30. Hoffmann-La Roche Ltd Company Information, Head Office, and Major Competitors
Table 31. Hoffmann-La Roche Ltd Major Business
Table 32. Hoffmann-La Roche Ltd Multicancer Detection Product and Solutions
Table 33. Hoffmann-La Roche Ltd Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Table 35. Fulgent Genetics. Company Information, Head Office, and Major Competitors
Table 36. Fulgent Genetics. Major Business
Table 37. Fulgent Genetics. Multicancer Detection Product and Solutions
Table 38. Fulgent Genetics. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Fulgent Genetics. Recent Developments and Future Plans
Table 40. Genecast Biotechnology Co., Ltd Company Information, Head Office, and Major Competitors
Table 41. Genecast Biotechnology Co., Ltd Major Business
Table 42. Genecast Biotechnology Co., Ltd Multicancer Detection Product and Solutions
Table 43. Genecast Biotechnology Co., Ltd Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Genecast Biotechnology Co., Ltd Recent Developments and Future Plans
Table 45. Guardant Health, Inc. Company Information, Head Office, and Major Competitors
Table 46. Guardant Health, Inc. Major Business
Table 47. Guardant Health, Inc. Multicancer Detection Product and Solutions
Table 48. Guardant Health, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Guardant Health, Inc. Recent Developments and Future Plans
Table 50. Illumina, Inc. Company Information, Head Office, and Major Competitors
Table 51. Illumina, Inc. Major Business
Table 52. Illumina, Inc. Multicancer Detection Product and Solutions
Table 53. Illumina, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Illumina, Inc. Recent Developments and Future Plans
Table 55. Konica Minolta, Inc. Company Information, Head Office, and Major Competitors
Table 56. Konica Minolta, Inc. Major Business
Table 57. Konica Minolta, Inc. Multicancer Detection Product and Solutions
Table 58. Konica Minolta, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Konica Minolta, Inc. Recent Developments and Future Plans
Table 60. Laboratory Corporation of America Holdings. Company Information, Head Office, and Major Competitors
Table 61. Laboratory Corporation of America Holdings. Major Business
Table 62. Laboratory Corporation of America Holdings. Multicancer Detection Product and Solutions
Table 63. Laboratory Corporation of America Holdings. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Laboratory Corporation of America Holdings. Recent Developments and Future Plans
Table 65. Myriad Genetics, Inc. Company Information, Head Office, and Major Competitors
Table 66. Myriad Genetics, Inc. Major Business
Table 67. Myriad Genetics, Inc. Multicancer Detection Product and Solutions
Table 68. Myriad Genetics, Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Myriad Genetics, Inc. Recent Developments and Future Plans
Table 70. Tempus Company Information, Head Office, and Major Competitors
Table 71. Tempus Major Business
Table 72. Tempus Multicancer Detection Product and Solutions
Table 73. Tempus Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Tempus Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Inc. Major Business
Table 77. Thermo Fisher Scientific Inc. Multicancer Detection Product and Solutions
Table 78. Thermo Fisher Scientific Inc. Multicancer Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 80. Global Multicancer Detection Revenue (USD Million) by Players (2018-2023)
Table 81. Global Multicancer Detection Revenue Share by Players (2018-2023)
Table 82. Breakdown of Multicancer Detection by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Multicancer Detection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Multicancer Detection Players
Table 85. Multicancer Detection Market: Company Product Type Footprint
Table 86. Multicancer Detection Market: Company Product Application Footprint
Table 87. Multicancer Detection New Market Entrants and Barriers to Market Entry
Table 88. Multicancer Detection Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Multicancer Detection Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Multicancer Detection Consumption Value Share by Type (2018-2023)
Table 91. Global Multicancer Detection Consumption Value Forecast by Type (2024-2029)
Table 92. Global Multicancer Detection Consumption Value by Application (2018-2023)
Table 93. Global Multicancer Detection Consumption Value Forecast by Application (2024-2029)
Table 94. North America Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Multicancer Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Multicancer Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Multicancer Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Multicancer Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Multicancer Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Multicancer Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Multicancer Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Multicancer Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Multicancer Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Multicancer Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Multicancer Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Multicancer Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Multicancer Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Multicancer Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Multicancer Detection Raw Material
Table 125. Key Suppliers of Multicancer Detection Raw Materials
LIST OF FIGURES
Figure 1. Multicancer Detection Picture
Figure 2. Global Multicancer Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Multicancer Detection Consumption Value Market Share by Type in 2022
Figure 4. Laboratory Developed Tests (LDTs)
Figure 5. In-Vitro Diagnostics (IVDs)
Figure 6. Global Multicancer Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Multicancer Detection Consumption Value Market Share by Application in 2022
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Global Multicancer Detection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Multicancer Detection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Multicancer Detection Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Multicancer Detection Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Multicancer Detection Consumption Value Market Share by Region in 2022
Figure 15. North America Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Multicancer Detection Revenue Share by Players in 2022
Figure 21. Multicancer Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Multicancer Detection Market Share in 2022
Figure 23. Global Top 6 Players Multicancer Detection Market Share in 2022
Figure 24. Global Multicancer Detection Consumption Value Share by Type (2018-2023)
Figure 25. Global Multicancer Detection Market Share Forecast by Type (2024-2029)
Figure 26. Global Multicancer Detection Consumption Value Share by Application (2018-2023)
Figure 27. Global Multicancer Detection Market Share Forecast by Application (2024-2029)
Figure 28. North America Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Multicancer Detection Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Multicancer Detection Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 38. France Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Multicancer Detection Consumption Value Market Share by Region (2018-2029)
Figure 45. China Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 48. India Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Multicancer Detection Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Multicancer Detection Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 62. Multicancer Detection Market Drivers
Figure 63. Multicancer Detection Market Restraints
Figure 64. Multicancer Detection Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Multicancer Detection in 2022
Figure 67. Manufacturing Process Analysis of Multicancer Detection
Figure 68. Multicancer Detection Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Multicancer Detection Picture
Figure 2. Global Multicancer Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Multicancer Detection Consumption Value Market Share by Type in 2022
Figure 4. Laboratory Developed Tests (LDTs)
Figure 5. In-Vitro Diagnostics (IVDs)
Figure 6. Global Multicancer Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Multicancer Detection Consumption Value Market Share by Application in 2022
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Global Multicancer Detection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Multicancer Detection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Multicancer Detection Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Multicancer Detection Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Multicancer Detection Consumption Value Market Share by Region in 2022
Figure 15. North America Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Multicancer Detection Revenue Share by Players in 2022
Figure 21. Multicancer Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Multicancer Detection Market Share in 2022
Figure 23. Global Top 6 Players Multicancer Detection Market Share in 2022
Figure 24. Global Multicancer Detection Consumption Value Share by Type (2018-2023)
Figure 25. Global Multicancer Detection Market Share Forecast by Type (2024-2029)
Figure 26. Global Multicancer Detection Consumption Value Share by Application (2018-2023)
Figure 27. Global Multicancer Detection Market Share Forecast by Application (2024-2029)
Figure 28. North America Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Multicancer Detection Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Multicancer Detection Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 38. France Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Multicancer Detection Consumption Value Market Share by Region (2018-2029)
Figure 45. China Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 48. India Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Multicancer Detection Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Multicancer Detection Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Multicancer Detection Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Multicancer Detection Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 62. Multicancer Detection Market Drivers
Figure 63. Multicancer Detection Market Restraints
Figure 64. Multicancer Detection Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Multicancer Detection in 2022
Figure 67. Manufacturing Process Analysis of Multicancer Detection
Figure 68. Multicancer Detection Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
